Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Appointed director
Notes underwriting agrmnt

Ayala Pharmaceuticals, Inc. (ADXS) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/29/2023 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
09/29/2023 3/A Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/01/2023 8-K Quarterly results
02/08/2023 SC 13G Redmile Group, LLC reports a 6.8% stake in AYALA PHARMACEUTICALS, Inc.
01/30/2023 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
01/30/2023 3 aMoon Growth Fund Limited Partnership (10% Owner) has filed a Form 3 on Ayala Pharmaceuticals, Inc.
01/30/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year  Interactive Data
01/30/2023 SC 13G Schindel Yair Chaim reports a 12.2% stake in Ayala Pharmaceutics, Inc
01/25/2023 8-K Completion of Acquisition or Disposition of Assets, Departure of Directors or Certain Officers; Election of Directors; Appoin...
01/23/2023 4 SIDRANSKY DAVID (Director) has filed a Form 4 on Ayala Pharmaceuticals, Inc.
Txns: Granted 46 shares @ $0
Granted 2,342 options @ $55.23, valued at $129.3k
Granted 2,342 options @ $8.7, valued at $20.4k
01/23/2023 4 GOLDBERG MURRAY A (Director) has filed a Form 4 on Ayala Pharmaceuticals, Inc.
Txns: Granted 3,279 options @ $27.21, valued at $89.2k
Granted 2,342 options @ $47.17, valued at $110.5k
Granted 1,171 options @ $55.23, valued at $64.7k
Granted 1,171 options @ $8.7, valued at $10.2k
01/23/2023 4 Bisker-Leib Vered (Director) has filed a Form 4 on Ayala Pharmaceuticals, Inc.
Txns: Granted 1,639 options @ $58.59, valued at $96k
Granted 1,171 options @ $55.23, valued at $64.7k
Granted 1,171 options @ $8.69, valued at $10.2k
01/23/2023 4 Spiegel Robert J. (Director) has filed a Form 4 on Ayala Pharmaceuticals, Inc.
Txns: Granted 3,279 options @ $27.21, valued at $89.2k
Granted 2,342 options @ $47.17, valued at $110.5k
Granted 1,171 options @ $55.23, valued at $64.7k
Granted 1,171 options @ $8.7, valued at $10.2k
01/23/2023 3 GOLDBERG MURRAY A (Director) has filed a Form 3 on Ayala Pharmaceuticals, Inc.
01/23/2023 3 Bisker-Leib Vered (Director) has filed a Form 3 on Ayala Pharmaceuticals, Inc.
01/23/2023 3 Spiegel Robert J. (Director) has filed a Form 3 on Ayala Pharmaceuticals, Inc.
01/13/2023 8-K Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure  Interactive Data
01/12/2023 425 Form 425 - Prospectuses and communications, business combinations:
01/12/2023 8-K Other Events  Interactive Data
12/13/2022 EFFECT Form EFFECT - Notice of Effectiveness:
12/12/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
12/12/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
12/08/2022 S-4/A Form S-4/A - Registration of securities, business combinations: [Amend]
12/02/2022 PRE 14A Form PRE 14A - Other preliminary proxy statements:
12/02/2022 425 Form 425 - Prospectuses and communications, business combinations:
12/02/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...
Docs: "ADVAXIS, INC. CERTIFICATE OF DESIGNATION OF SERIES E PREFERRED STOCK Pursuant to Section 151 of the General Corporation Law of the State of Delaware THE UNDERSIGNED DOES HEREBY CERTIFY, on behalf of Advaxis, Inc., a Delaware corporation , that the following resolution was duly adopted by the board of directors of the Corporation , in accordance with the provisions of Section 151 of the General Corporation Law of the State of Delaware, as amended on November 16, 2022, which resolution provides for the creation of a series of the Corporation’ s Preferred Stock, par value $0.001 per share, which is designated as “Series E Preferred Stock,” with the rights, preferences, privileges and restrictions set forth therein. WHEREAS, the Amended and Restated Certificate of Incorporation of the Corporat...",
"SECURITIES PURCHASE AGREEMENT"
11/29/2022 S-4 Form S-4 - Registration of securities, business combinations:
10/19/2022 425 Form 425 - Prospectuses and communications, business combinations:
10/19/2022 8-K Quarterly results
07/01/2022 8-K Quarterly results
06/27/2022 RW Form RW - Registration Withdrawal Request:
06/24/2022 8-K Quarterly results
06/10/2022 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy